Attached files

file filename
EX-99.1 - EXHIBIT 99.1 - VANGUARD HEALTH SYSTEMS INCc23895exv99w1.htm
EX-99.2 - EXHIBIT 99.2 - VANGUARD HEALTH SYSTEMS INCc23895exv99w2.htm
8-K - FORM 8-K - VANGUARD HEALTH SYSTEMS INCc23895e8vk.htm
EXHIBIT 99.3
VANGUARD HEALTH SYSTEMS, INC.
Calculation of Certain Financial Covenants under Senior Secured Credit Agreement
September 30, 2011
         
    Trailing  
    twelve  
    months ended  
    September 30,  
($ presented in millions)   2011  
Interest Coverage Ratio:
       
Adjusted EBITDA(1)
  $ 468.1  
Add: Pro Forma adjustments for fiscal 2011 and 2012 acquisitions
    68.6  
Add: Equity method cash distributions received
    1.3  
Less: Non-controlling interest distributions paid
    (3.5 )
Add: Franchise tax expense
    0.2  
Add: Gross interest income recognized
    2.4  
Add: Capitalized interest recorded
    5.2  
 
     
Consolidated EBITDA, as defined in senior secured credit agreement
  $ 542.3 A
 
       
Net interest
  $ 182.2  
Add: Capitalized interest recorded
    5.2  
Less: Non-cash accretion of senior discount and senior unsecured notes
    (26.6 )
Less: Non-cash amortization of financing costs
    (6.6 )
Less: Interest related to specified construction projects
    (7.2 )
 
     
Consolidated cash interest expense, as defined in senior secured credit agreement
  $ 147.0 B
 
       
Interest coverage ratio (A/B)
    3.69 x
 
     
 
       
Minimum interest coverage ratio required as of September 30, 2011
    2.10 x
 
     
         
    As of  
    September 30,  
    2011  
Leverage Ratio:
       
Term debt and senior notes outstanding
  $ 2,331.4  
Less: Cash and cash equivalents
    (154.7 )
Less: Restricted cash
    (2.4 )
Less: Debt incurred to fund specified construction projects
    (127.2 )
 
     
Consolidated debt, as defined in senior secured credit agreement
  $ 2,047.1 C
 
       
Consolidated EBITDA, as defined in senior secured credit agreement
  $ 542.3 A
 
       
Leverage ratio (C/A)
    3.77 x
 
     
 
       
Maximum leverage ratio allowed as of September 30, 2011
    5.95 x
 
     

 


 

VANGUARD HEALTH SYSTEMS, INC.
Calculation of Certain Financial Covenants under Senior Secured Credit Agreement
September 30, 2011
(continued)
 
     
(1)  
Adjusted EBITDA is defined as income before interest expense (net of interest income), income taxes, depreciation and amortization, non-controlling interests, gain or loss on disposal of assets, equity method income, stock compensation, monitoring fees and expenses, realized gains or losses on investments, debt extinguishment costs, acquisition related expenses, impairment and restructuring charges and discontinued operations, net of taxes. Adjusted EBITDA is not intended as a substitute for net income (loss) attributable to Vanguard Health Systems, Inc. stockholders, operating cash flows or other cash flow statement data determined in accordance with accounting principles generally accepted in the United States. Due to varying methods of calculation, Adjusted EBITDA as presented may not be comparable to similarly titled measures of other companies. The following table provides a reconciliation of Adjusted EBITDA to net income (loss) attributable to Vanguard Health Systems, Inc. stockholders during the trailing twelve months ended September 30, 2011 (in millions).
                                 
            Add:     Less:     Trailing  
    Three months     Year     Three months     twelve months  
    ended     ended     ended     ended  
    September 30,     June 30,     September 30,     September 30,  
    2011     2011     2010     2011  
Net income (loss) attributable to Vanguard Health Systems, Inc. stockholders
  $ (19.2 )   $ (10.9 )   $ 1.2     $ (31.3 )
Interest, net
    45.8       171.2       34.8       182.2  
Income tax expense (benefit)
    (13.6 )     9.3       (2.4 )     (1.9 )
Depreciation and amortization
    62.6       193.8       37.2       219.2  
Non-controlling interests
    (2.3 )     3.6       1.0       0.3  
Gain on disposal of assets
    (1.2 )     (0.2 )           (1.4 )
Equity method income
    (0.1 )     (0.9 )     (0.3 )     (0.7 )
Stock compensation
    0.7       4.8       1.2       4.3  
Monitoring fees and expenses
          31.3       1.4       29.9  
Realized gains on investments
          (1.3 )           (1.3 )
Debt extinguishment costs
    38.9                   38.9  
Acquisition related expenses
    12.2       12.5       3.7       21.0  
Impairment and restructuring charges
    (0.1 )     6.0             5.9  
Pension credits
    (1.0 )     (2.1 )           (3.1 )
Discontinued operations, net of taxes
    0.1       5.9       (0.1 )     6.1  
 
                       
Adjusted EBITDA
  $ 122.8     $ 423.0     $ 77.7     $ 468.1